EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Artificial Intelligence in Scalable Materials Synthesis and Manufacturing

Nagababu Andraju

AI Chemistry · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

While Artificial Intelligence (AI) has transformed materials discovery, the primary bottleneck to technological impact remains the transition from lab-scale synthesis to robust, industrial-scale manufacturing. Most promising materials perish in this depth, which is referred as the “valley of death”. The current review consolidates and critically evaluates the emerging ecosystem of AI-driven strategies and frameworks designed specifically to bridge this “lab-to-fab” gap. The review shifts our attention from property prediction to the engineering-driven problems of manufacturability. Furthermore, the review discusses the main obstacles to scaling the production of materials, such as reproducibility, process optimization in the context of uncertainty, and techno-economic viability, as well as the AI approaches being developed to overcome them. This includes Natural Language Processing (NLP) for method extraction, graph neural networks for reaction modeling, reinforcement learning for process control, Bayesian optimization for definition of process windows, and integrated AI–Techno-Economic Analysis (TEA) frameworks. Equally importantly, the review examines the principal failure modes that constrain practical deployment, including out-of-distribution generalization, incomplete and non-transferable literature-derived data, simulator-to-plant mismatch, uncertainty miscalibration, and the continued need for expert oversight. The article concludes with a forward-looking roadmap for the future of AI in chemical and materials engineering. The proposed conclusion is defined by a paradigm shift from simply finding new materials to creating viable, economical, and scalable pathways to produce them, thereby enabling a new era of synthesis-aware materials innovation.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Nagababu Andraju
Quelle
AI Chemistry
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
3042-6723
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Nagababu Andraju (2026). Artificial Intelligence in Scalable Materials Synthesis and Manufacturing. AI Chemistry. https://doi.org/10.3390/aichem1030014
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1